Human P2Y1 receptor:: Molecular modeling and site-directed mutagenesis as tools to identify agonist and antagonist recognition sites

被引:142
作者
Moro, S
Guo, DP
Camaioni, E
Boyer, JL
Harden, TK
Jacobson, KA
机构
[1] NIDDK, Mol Recognit Sect, NIH, LBC, Bethesda, MD 20892 USA
[2] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA
关键词
D O I
10.1021/jm970684u
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The molecular basis for recognition by human P2Y(1) receptors of the novel, competitive antagonist 2'-deoxy-N-6-methyladenosine 3',5'-bisphosphate (MRS 2179) was probed using site-directed mutagenesis and molecular modeling. The potency of this antagonist was measured in mutant receptors in which key residues in the transmembrane helical domains (TMs) 3, 5, 6, and 7 were replaced by Ala or other amino acids. The capacity of MRS 2179 to block stimulation of phospholipase C promoted by 2-methylthioadenosine 5'-diphosphate (2-MeSADP) was lost in P2Y(1) receptors having F226A, K280A, or Q307A mutations, indicating that these residues are critical for the binding of the antagonist molecule. Mutation of the residues His132, Thr222, and Tyr136 had an intermediate effect on the capacity of MRS 2179 to block the P2Y(1) receptor. These positions therefore appear to have a modulatory role in recognition of this antagonist. F131A, H277A, T221A, R310K, or S317A mutant receptors exhibited an apparent affinity for PARS 2179 that was similar to that observed with the wild-type receptor. Thus, Phe131, Thr221, His277, and Ser317 are not essential for antagonist recognition. A computer-generated model of the human P2Y(1) receptor was built and analyzed to help interpret these results. The model was derived through primary sequence comparison, secondary structure prediction, and three-dimensional homology building, using rhodopsin as a template, and was consistent with data obtained from mutagenesis studies. We have introduced a "cross-docking" procedure to obtain energetically refined 3D structures of the Ligand-receptor complexes. Cross-docking simulates the reorganization of the native receptor structure induced by a ligand. A putative nucleotide binding site was localized and used to predict which residues are likely to be in proximity to agonists and antagonists. According to our model TM6 and TM7 are close to the adenine ring, TM3 and TM6 are close to the ribose moiety, and TM3, TM6, and TM7 are near the triphosphate chain.
引用
收藏
页码:1456 / 1466
页数:11
相关论文
共 30 条
[1]  
[Anonymous], [No title captured]
[2]   CHANGES IN THE LEVELS OF INOSITOL PHOSPHATES AFTER AGONIST-DEPENDENT HYDROLYSIS OF MEMBRANE PHOSPHOINOSITIDES [J].
BERRIDGE, MJ ;
DAWSON, RMC ;
DOWNES, CP ;
HESLOP, JP ;
IRVINE, RF .
BIOCHEMICAL JOURNAL, 1983, 212 (02) :473-482
[3]  
Burnstock G, 1996, DRUG DEVELOP RES, V38, P67, DOI 10.1002/(SICI)1098-2299(199605)38:1<67::AID-DDR9>3.0.CO
[4]  
2-J
[5]  
BURNSTOCK G, 1997, PURINERGIC APPROACHE
[6]   Deoxyadenosine bisphosphate derivatives as potent antagonists at P2Y1 receptors [J].
Camaioni, E ;
Boyer, JL ;
Mohanram, A ;
Harden, TK ;
Jacobson, KA .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (02) :183-190
[7]  
CHIOTA C, 1981, J MOL BIOL, V145, P215
[8]  
CULLEN BR, 1987, METHOD ENZYMOL, V152, P684
[9]   THE DEVELOPMENT AND USE OF QUANTUM-MECHANICAL MOLECULAR-MODELS .76. AM1 - A NEW GENERAL-PURPOSE QUANTUM-MECHANICAL MOLECULAR-MODEL [J].
DEWAR, MJS ;
ZOEBISCH, EG ;
HEALY, EF ;
STEWART, JJP .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1985, 107 (13) :3902-3909
[10]   SITE-DIRECTED MUTAGENESIS OF P-2U PURINOCEPTORS - POSITIVELY CHARGED AMINO-ACIDS IN TRANSMEMBRANE HELIX-6 AND HELIX-7 AFFECT AGONIST POTENCY AND SPECIFICITY [J].
ERB, L ;
GARRAD, R ;
WANG, YJ ;
QUINN, T ;
TURNER, JT ;
WEISMAN, GA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (09) :4185-4188